يعرض 2,541 - 2,560 نتائج من 21,342 نتيجة بحث عن '(( significant decrease decrease ) OR ( significant clinical decrease ))', وقت الاستعلام: 0.33s تنقيح النتائج
  1. 2541

    Baseline demographic characteristics. حسب Jung-Tae Kim (8997767)

    منشور في 2025
    الموضوعات:
  2. 2542
  3. 2543

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

    منشور في 2025
    "…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…"
  4. 2544

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

    منشور في 2025
    "…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…"
  5. 2545

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms حسب Farman M. Abbasi (22318766)

    منشور في 2025
    "…In ovariectomized mice, <b>5cc</b> administration (5 mg/kg) improved the trabecular microarchitecture, bone mineral density, and strength, at levels comparable to teriparatide, while significantly reducing bone resorption markers. With 13.57% oral bioavailability and selectivity for PDE1A1 (32% inhibition at 500 nM), <b>5cc</b> offers an innovative therapeutic candidate for PMO with a dual anabolic-antiresorptive profile and oral efficacy, warranting further clinical development.…"
  6. 2546

    Baseline Characteristics of Study Participants. حسب Swati M. Surkar (8399427)

    منشور في 2025
    "…The results demonstrate that DT training significantly improves and retains DT performance, likely due to a reduction in cognitive-motor interference. …"
  7. 2547

    Raw and processed data files. حسب Swati M. Surkar (8399427)

    منشور في 2025
    "…The results demonstrate that DT training significantly improves and retains DT performance, likely due to a reduction in cognitive-motor interference. …"
  8. 2548
  9. 2549
  10. 2550
  11. 2551

    Busulfan treatment induces orchitis. حسب Lingjun Zhao (21763122)

    منشور في 2025
    الموضوعات:
  12. 2552
  13. 2553
  14. 2554
  15. 2555
  16. 2556
  17. 2557
  18. 2558
  19. 2559
  20. 2560